The late consequences of anthracycline treatment on left ventricular function after treatment for childhood cancer

European Journal of Pediatrics

Volumn 162, Issue 10, 2003, Pages 690-696

  Elbl, Lubomir ^a   Hrstkova, Hana ^a   Chaloupka, Vaclav ^a  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

Anthracyclines; Childhood malignancy; Echocardiography; Late cardiotoxicity

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; DAUNORUBICIN; DOXORUBICIN;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CARDIOMYOPATHY; CARDIOTOXICITY; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTOLE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIBIOTICS, ANTINEOPLASTIC; CHILD; CHILD, PRESCHOOL; DAUNORUBICIN; DOXORUBICIN; FEMALE; HUMANS; MALE; NEOPLASMS; REGRESSION ANALYSIS; REMISSION INDUCTION; VENTRICULAR FUNCTION, LEFT;

EID: 0141889823     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-003-1275-y     Document Type: Article

References (29)

1. Bigras JL, McCrindle BW, Shibuya K, Smallhorn JF (1998) Abnormal ultrasonic tissue characterization of the myocardium in children receiving doxorubicin for cancer therapy. Echocardiography 15: 121-125
2. Billingham ME, Masek MA (1993) The pathology of anthracycline cardiotoxicity in children, adolescents and adults. In: Bricker JT, Green DM, D'Angio G (eds) Cardiac toxicity after treatment for childhood cancer. Wiley-Liss, New York, pp 17-24
3. Bu'Lock FA, Mott MG, Oakhill A, Martin RP (1995) Left ventricular diastolic function after anthracycline chemotherapy in childhood: relation with systolic function, symptoms and pathophysiology. Br Heart J 73: 340-350
4. Bu'Lock FA, Mott MG, Oakhill A, Martin RP (1996) Early identification of anthracycline cardiomyopathy: possibilities and implications. Arch Dis Child 75: 416-420
5. Bu'Lock FA, Mott MG, Oakhill A, Martin RP (1999) Left ventricular diastolic filling patterns associated with progressive anthracycline-induced myocardial damage: a prospective study. Pediatr Cardiol 20: 252-263
6. Eidem BW, Sapp BG, Suarez CR, Cetta F (2001) Usefulness of the myocardial performance index for early detection of anthracycline-induced cardiotoxicity in children. Am J Cardiol 87: 1120-1122
7. Giantris A, Abdurrahman L, Hinkle A, Asselin B, Lipshultz SE (1998) Anthracycline-induced cardiotoxicity in children and young adults. Critical Rev Oncol Hematol 4: 53-68
8. Grenier MA, Lipshultz SE (1998) Epidemiology of anthracycline cardiotoxicity in children and adults. Semin Oncol 25: 72-85
9. 9. Hashimoto I, Ichida F, Miura M, Okabe T, Kanegane H, Uese K, Hamamichi Y, Misaki T, Koizumi S, Miyawaki T (1999) Automatic border detection identifies subclinical anthracycline cardiotoxicity in children with malignancy. Circulation 99: 2367-2370
10. Herman EH, Ferrans VJ (1993) Pathophysiology of anthracycline cardiotoxicity. In: Bricker JT, Green DM, D'Angio G (eds): Cardiac toxicity after treatment for childhood cancer. Wiley-Liss, New York pp 25-34
11. Hesseling PB, Kalis NN, Wessels G, van der Merwe PL (1999) The effect of anthracyclines on myocardial function in 50 long-term survivors of childhood cancer. S Afr Med J 89: C25-C28
12. Iarussi D, Galderisi M, Raitti G, Tedesco MA, Indolfi P, Casale F, DiTullio TM, de Divitiis O, Ioacono A (2001) Left ventricular systolic and diastolic function after anthracycline chemotherapy in childhood. Clin Cardiol 24: 663-669
13. Johnson GL, Moffett CB, Geil JD, Greenwood MF, Noonan JA (1996) Late echocardiographic findings following childhood chemotherapy with normal serial cardiac monitoring. J Pediatr Hematol 18: 72-75
14. Kapusta L, Thijssen JM, Groot-Loonen J, Antonius T, Mulder J, Daniels O (2000) Tissue Doppler imaging in detection of myocardial dysfunction in survivors of childhood cancer treated with anthracyclines. Ultrasound Med Biol 26: 1099-1108
15. Kremer LCM, van Dalen EC, Offringa M, Ottenkamp J, Voute PA (2001) Anthracycline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study. J Clin Oncol 19: 191-196
16. Kremer LCM, van der Pal HJH, Offringa M, van Dalen EC, Voute PA (2002) Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review. Ann Oncol 13: 819-829
17. Leonardo J, Dyck J, Poppe D, Shore R, Airhart C, Greenberg M, Gilday D, Smallhorn J, Benson L (1994) Cardiac dysfunction late after cardiotoxic therapy for childhood cancer. Am J Cardiol 74: 1152-1156
18. Lentner C (1990) Heart and circulation. Geigy Scientific Tables Volume V. Ciba-Geigy Corporation, Medical Education Division, West Caldwell, New Jersey, pp 116-120
19. Li CK, Sung RT, Kwok KL, Leung TF, Shing MM, Chik KW, Yu CW, Yam MC, Yuen PM (2000) A longitudinal study of cardiac function in children with cancer over 40 months. Pediatr Hematol Oncol 17: 77-83
20. Lipshultz SE, Colan SD (1993) The use of echocardiography and Holter monitoring in the assessment of anthracycline-treated patients. In: Bricker JT, Green DM, D'Angio G (eds) Cardiac toxicity after treatment for childhood cancer. Wiley-Liss, New York, pp 45-62
21. Nysom K, Colan SD, Lipshultz SE (1998) Late cardiotoxicity following anthracycline therapy for childhood cancer. Progress Pediatr Cardiol 8: 121-138
22. Otto CM, Pearlman AS (1995) Textbook of clinical echocardiography, 1st edn. Saunders, Philadelphia
23. Shan K, Lincoff M, Young JB (1996) Anthracycline-induced cardiotoxicity. Ann Intern Med 125: 47-58
24. Sorensen K, Levitt G, Sebag-Montefiore D, Bull C, Sullivan I (1995) Cardiac function in Wilm's tumor survivors. Am J Clin Oncol 13: 1546-1556
25. Steinherz LJ, Steinherz PG, Tan CTC (1991) Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA 266: 1672-1677
26. Steinherz LJ, Graham T, Hurwitz R (1992) Guidelines for cardiac monitoring of children during and after anthracycline therapy: report of the Cardiology Committee of the Childrens Cancer Study Group. Pediatrics 89: 942-948
27. Tei C, Ling LH, Hodge DO, Bailey KL, Oh JK, Rodeheffer RJ, Tajik JA. Seward JB (1995) New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function - a study in normals and dilated cardiomyopathy. J Cardiol 26: 357-366
28. Von Hoff DD, Rozencweig M, Layard M, Slavik M, Muggia FM (1977) Daunomycin-induced cardiotoxicity in children and adults. Am J Med 62: 200-208
29. Von Hoff DD, Layard MW, Basa P, Davis HL, Von Hoff AL, Rozencweig M, Muggia FM (1979) Risk factors for doxorubicin-induced congestive heart failure. Ann Int Med 91: 710-717